Endothelial nitric oxide synthase limits the inflammatory response in mouse cutaneous leishmaniasis

Immunobiology

Volumn 215, Issue 9-10, 2010, Pages 826-832

  Fritzsche, Carlos ^a   Schleicher, Ulrike ^a   Bogdan, Christian ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

ENOS; Leishmania; Nitric oxide; T cells

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; FEMALE; GRANULOCYTE; HOST PARASITE INTERACTION; IN VITRO STUDY; INFLAMMATION; LEISHMANIA MAJOR; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN LEISHMANIASIS; T LYMPHOCYTE; TH1 CELL; TH2 CELL; WILD TYPE;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; DISEASE PROGRESSION; GRANULOCYTES; INTERFERON-GAMMA; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; SKIN; T-LYMPHOCYTES;

EID: 77955472335     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.05.022     Document Type: Article

References (53)

1. Ahluwalia A., Foster P., Scotland R.S., McLean P.G., Mathur A., Perretti M., Moncada S., Hobbs A.J. Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment. Proc. Natl. Acad. Sci. USA 2004, 101:1386-1391.
2. Anderson C.F., Mendez S., Sacks D.L. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice. J. Immunol. 2005, 174:2934-2941.
3. Barna M., Komatsu T., Reiss C.S. Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection. Virology 1996, 15:332-343.
4. Beck P.L., Xavier R., Wong J., Ezedi I., Mashimo H., Mizoguchi A., Mizoguchi E., Bhan A.K., Podolsky D.K. Paradoxical roles of different nitric oxide synthase isoforms in colonic injury. Am. J. Physiol. Gastrointest. Liver. Physiol. 2004, 286:G137-G147.
5. Blos M., Schleicher U., Rocha F.J., Meissner U., Röllinghoff M., Bogdan C. Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase. Eur. J. Immunol. 2003, 33:1224-1234.
6. Bogdan C. The function of nitric oxide in the immune system. Handbook of Experimental Pharmacology. Volume: Nitric Oxide 2000, 443-492. Springer, Heidelberg. B. Mayer (Ed.).
7. Bogdan C., Donhauser N., Döring R., Röllinghoff M., Diefenbach A., Rittig M.G. Fibroblasts as host cells in latent leishmaniosis. J. Exp. Med. 2000, 191:2121-2129.
8. Bogdan C. Nitric oxide and the immune response. Nat. Immunol. 2001, 2:907-916.
9. Bogdan C. Phagocyte effector functions against Leishmania parasites. Protozoans in Macrophages 2007, 193-206. Landes Bioscience, Austin, Texas. E.Y. Denkers, R.T. Gazzinelli (Eds.).
10. Bogdan C. Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. Cell. Microbiol. 2008, 10:1221-1234.
11. Chen C., Chai H., Wang X., Lin P.H., Yao Q. Chlamydia heat shock protein 60 decreases expression of endothelial nitric oxide synthase in human and porcine coronary artery endothelial cells. Cardiovasc. Res. 2009, 83:768-777.
12. Connelly L., Jacobs A.T., Palacios-Callender M., Moncada S., Hobbs A.J. Macrophage endothelial nitric oxide synthase autoregulates cellular activation and proinflammatory protein expression. J. Biol. Chem. 2003, 278:26480-26487.
13. Diefenbach A., Schindler H., Donhauser N., Lorenz E., Laskay T., MacMicking J., Röllinghoff M., Gresser I., Bogdan C. Type 1 interferon (IFN-α/Β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 1998, 8:77-87.
14. Diefenbach A., Schindler H., Röllinghoff M., Yokoyama W., Bogdan C. Requirement for type 2 NO-synthase for IL-12 responsiveness in innate immunity. Science 1999, 284:951-955.
15. Forstermann U., Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006, 113:1708-1714.
16. Hallmann R., Savigni D.L., Morgan E.H., Baker E. Characterization of iron uptake from transferrin by murine endothelial cells. Endothelium 2000, 7:135-147.
17. Ibiza S., Victor V.M., Bosca I., Ortega A., Urzainqui A., O'Connor J.E., Sanchez-Madrid F., Esplugues J.V., Serrador J.M. Endothelial nitric oxide synthase regulates T cell receptor signaling at the immunological synapse. Immunity 2006, 24:753-765.
18. Ibiza S., Perez-Rodriguez A., Ortega A., Martinez-Ruiz A., Barreiro O., Garcia-Dominguez C.A., Victor V.M., Esplugues J.V., Rojas J.M., Sanchez-Madrid F., Serrador J.M. Endothelial nitric oxide synthase regulates N-Ras activation on the Golgi complex of antigen-stimulated T cells. Proc. Natl. Acad. Sci. USA 2008, 105:10507-10512.
19. Iwase K., Miyanaka K., Shimizu A., Nagasaki A., Gotoh T., Mori M., Takiguchi M. Induction of endothelial nitric oxide synthase in rat brain astrocytes by systemic lipopolysaccharide treatment. J. Biol. Chem. 2000, 275:11929-11933.
20. Kang W.S., Tamarkin F.J., Wheeler M.A., Weiss R.M. Rapid up-regulation of endothelial nitric-oxide synthase in a mouse model of Escherichia coli lipopolysaccharide-induced bladder inflammation. J. Pharmacol. Exp. Ther. 2004, 310:452-458.
21. Kebaier C., Louzir H., Chenik M., Salah A.B., Dellagi K. Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response. Infect. Immun. 2001, 69:4906-4915.
22. Koedel U., Paul R., Winkler F., Kastenbauer S., Huang P.L., Pfister H.W. Lack of endothelial nitric oxide synthase aggravates murine pneumococcal meningitis. J. Neuropathol. Exp. Neurol. 2001, 60:1041-1050.
23. Kubes P., Suzuki M., Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 1991, 88:4651-4655.
24. Laskay T., van Zandbergen G., Solbach W. Neutrophil granulocytes as host cells and transport vehicles for intracellular pathogens: apoptosis as infection-promoting factor. Immunobiology 2008, 213:183-191.
25. Lee P.C., Salyapongse A.N., Bragdon G.A., Shears L.L., Watkins S.C., Edington H.D., Billiar T.R. Impaired wound healing and angiogenesis in eNOS-deficient mice. Am. J. Physiol. 1999, 277:H1600-H1608.
26. Lefer D.J., Jones S.P., Girod W.G., Baines A., Grisham M.B., Cockrell A.S., Huang P.L., Scalia R. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am. J. Physiol. 1999, 276:H1943-H1950.
27. Li H., Wallerath T., Förstermann U. Physiological mechanisms regulating the expression of endothelial-type NO synthase. Nitric Oxide 2002, 7:132-147.
28. Liese J., Schleicher U., Bogdan C. TLR9 signalling is essential for the innate NK cell response in murine cutaneous leishmaniasis. Eur. J. Immunol. 2007, 37:3424-3434.
29. Lohoff M., Schmitt E., Reske-Kunz A.B., Röllinghoff M. Different response of Th1 cells for stimulation with anti-CD3 antibodies. Eur. J. Immunol. 1990, 20:653-658.
30. Lykens J.E., Terrell C.E., Zoller E.E., Divanovic S., Trompette A., Karp C.L., Aliberti J., Flick M.J., Jordan M.B. Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivo. J. Immunol. 2010, 184:877-885.
31. Mattner J., Wandersee-Steinhäuser A., Pahl A., Röllinghoff M., Majeau G.R., Hochman P.S., Bogdan C. Protection against progressive leishmaniasis by IFN-Β. J. Immunol. 2004, 172:7574-7582.
32. Miles P.R., Bowman L., Rengasamy A., Huffman L. Constitutive nitric oxide production by rat alveolar macrophages. Am. J. Physiol. 1998, 274:L360-L368.
33. Naseem K.M. The role of nitric oxide in cardiovascular diseases. Mol. Aspects Med. 2005, 26:33-65.
34. Reiling N., Ulmer A.J., Duchrow M., Ernst M., Flad H.-D., Hauschildt S. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur. J. Immunol. 1994, 24:1941-1944.
35. 2+/calmodulin-dependent isoform in human B and T lymphocytes. Eur. J. Immunol. 1996, 26:511-516.
36. Roman V., Dugas N., Abadie A., Amirand C., Zhao H., Dugas B., Kolb J.-P. Characterization of a constitutive type III nitric oxide synthase in human U937 monocytic cells: stimulation by soluble CD23. Immunology 1997, 91:643-648.
37. Rosypal A.C., Lindsay D.S., Duncan R., Ahmed S.A., Zajac A.M., Dubey J.P. Mice lacking the gene for inducible or endothelial nitric oxide are resistant to sporocyst induced Sarcocystis neurona infections. Vet. Parasitol. 2002, 103:315-321.
38. Sacks D.L., Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2002, 2:845-858.
39. Schindler H., Lutz M.B., Röllinghoff M., Bogdan C. The production of IFN-γ by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4. J. Immunol. 2001, 166:3075-3082.
40. Schleicher U., Mattner J., Blos M., Schindler H., Röllinghoff M., Karaghiosoff M., Müller M., Werner-Felmayer G., Bogdan C. Control of Leishmania major in the absence of Tyk2 kinase. Eur. J. Immunol. 2004, 34:519-529.
41. + NK cells are the source of IFN-γ in IL-12/IL-18-stimulated mouse macrophage populations. Blood 2005, 105:1319-1328.
42. Schmitt E., van Brandwijk R., van Snick J., Siebold B., Rüde E. TCGF III/P40 is produced by naive murine CD4+ T cells but is not a general T cell growth factor. Eur. J. Immunol. 1989, 19:2167.
43. Sciorati C., Rovere P., Ferrarini M., Heltai S., Manfredi A.A., Clementi E. Autocrine nitric oxide modulates CD95-induced apoptosis in γ T lymphocytes. J. Biol. Chem. 1997, 272:23211-23215.
44. Stenger S., Donhauser N., Thüring H., Röllinghoff M., Bogdan C. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 1996, 183:1501-1514.
45. Stuehr D.J., Santolini J., Wang Z.-Q., Wei C.-C., Adak S. Update on mechanism and catalytic regulation in the NO synthases. J. Biol. Chem. 2004, 279:36167-36170.
46. Thüring H., Stenger S., Gmehling D., Röllinghoff M., Bogdan C. Lack of inducible nitric oxide synthase activity in T cell-clones and T lymphocytes from naive and Leishmania major-infected mice. Eur. J. Immunol. 1995, 25:3229-3234.
47. Vallance B.A., Dijkstra G., Qiu B., van der Waaij L.A., van Goor H., Jansen P.L., Mashimo H., Collins S.M. Relative contributions of NOS isoforms during experimental colitis: endothelial-derived NOS maintains mucosal integrity. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287:G865-G874.
48. van der Heyde H.C., Gu Y., Zhang Q., Sun G., Grisham M.B. Nitric oxide is neither necessary nor sufficient for resolution of Plasmodium chabaudi malaria in mice. J. Immunol. 2000, 165:3317-3323.
49. van Zandbergen G., Klinger M., Mueller A., Dannenberg S., Gebert A., Solbach W., Laskay T. Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J. Immunol. 2004, 173:6521-6525.
50. Viswambharan H., Seebeck T., Yang Z. Enhanced endothelial nitric oxide-synthase activity in mice infected with Trypanosoma brucei. Int. J. Parasitol. 2003, 33:1099-1104.
51. Winkler F., Koedel U., Kastenbauer S., Pfister H.W. Differential expression of nitric oxide synthases in bacterial meningitis: role of the inducible isoform for blood-brain barrier breakdown. J. Infect. Dis. 2001, 183:1749-1759.
52. Ying L., Hofseth L.J. An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res. 2007, 67:1407-1410.
53. Zhou L., Zhu D.Y. Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide 2009, 20:223-230.